Learn how medications that target the nitric oxide pathway help widen blood vessels in the lungs and improve blood flow in pulmonary hypertension. Christopher King explains the two categories of medications within this pathway, how they work, potential side effects, and important safety considerations, including why multiple medications within this class are NOT used together.

Speaker

Christopher King, MD, FCCP
Associate Medical Director, Advanced Lung Disease and Transplant Program
PFF Center Director
Associate Medical Director, PAH and CTEPH Program
System Director, Respiratory Care Services